Fny Investment Advisers, LLC Capricor Therapeutics, Inc. Transaction History
Fny Investment Advisers, LLC
- $194 Million
- Q4 2024
A detailed history of Fny Investment Advisers, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 625 shares of CAPR stock, worth $8,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
625Holding current value
$8,325% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
96Shares Held
8.18MCall Options Held
1.78MPut Options Held
1.4M-
Black Rock Inc. New York, NY1.63MShares$21.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA638KShares$8.5 Million0.0% of portfolio
-
State Street Corp Boston, MA512KShares$6.82 Million0.0% of portfolio
-
Superstring Capital Management LP New York, NY337KShares$4.49 Million4.49% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $324M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...